Tertiary Prevention in Type II Diabetes Mellitus in Canary Islands Study
INDICA
Effectiveness and Cost-effectiveness of Two Multi-component Interventions to Improve the Health Outcomes in People With Type 2 Diabetes Mellitus
1 other identifier
interventional
2,334
1 country
1
Brief Summary
Objective:
- To improve health outcomes of patients with type 2 diabetes mellitus (T2DM) by influencing disease self-management through lifestyle modification and by helping primary care professionals to improve health care provided to patients.
- To assess the effectiveness and cost-effectiveness of two complex interventions (education and behavioural modification, independently and conjointly, for primary health care teams (PHCT) and patients and their relatives) to improve the health results in people with T2DM. Methodology: Design: Randomized clinical trial. Setting: Basic healthcare district in Canary Islands. Spain. Subjects: Patients with T2DM, 18-65 years old, without complications. Main measures: HbA1c, rate of patients with properly controlled T2DM. Sample: 2328 patients, 582 per arm. Intervention: G1: Interventions on the patients: Educational and habit modification group program. G2: Intervention on the PHCT: a) Educative intervention to improve the knowledge about the disease and their abilities; b) Computer-based clinical decision support system; c) Feedback of results. G3: Interventions on the patients and the PHCT. G4: Control group. Patients receive only the usual care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable type-2-diabetes-mellitus
Started Jan 2013
Longer than P75 for not_applicable type-2-diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2012
CompletedFirst Posted
Study publicly available on registry
August 6, 2012
CompletedStudy Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 20, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 20, 2016
CompletedOctober 4, 2021
September 1, 2021
3.8 years
July 31, 2012
September 27, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Glycosylated hemoglobin (HbA1c)
Change in Glycosylated hemoglobin from baseline to 12 months
Baseline and 12 months
Secondary Outcomes (22)
Change in Glycosylated hemoglobin (HbA1c)
Baseline and 3, 6, 18 and 24 months
Change in Weight
Baseline and 3, 6, 12, 18 and 24 months
Change in Waist circumference
Baseline and 3, 6, 12, 18 and 24 months
Change in Body Mass Index (BMI)
Baseline and 3, 6,12, 18 and 24m
Change in Basal glucose
Baseline and 3, 6, 12, 18 and 24 months
- +17 more secondary outcomes
Other Outcomes (3)
Incidence of micro- and macrovascular complications
Baseline, 12 and 24 months
Quality measures of the T2DM care process
Baseline and 6, 12, 18 and 24 months
Resource utilization and costs
Baseline and 3, 6, 12, 18 and 24 months
Study Arms (4)
Intervention to Patients
EXPERIMENTALOnly patients receive intervention
Intervention to healthcare Professionals
EXPERIMENTALPrimary care physicians and nurses practitioners receive the intervention. Their associated patients do not receive direct intervention although indirect intervention through professionals
Mixed Intervention
EXPERIMENTALPatients and healthcare professionals (primary care physicians and nurses practitioners) associated with these patients receive intervention
Control
OTHERPatients receive usual care
Interventions
Multifaceted intervention consisting of: * Program of education and behavior modification: group sessions conducted by health educators for the patient and a relative (who usually do the food shopping or prepare meals) every 3 months over 2 years (total:8 sessions). Main contents: diabetes, hygiene/nutrition and physical exercise. * Monitoring of patient conditions by Informational Communication Technologies (ICT): patient will complete at home a web-based short questionnaire once a week and an expanded version once a month. * Short text messaging to patient's mobile based on information obtained from self-reported questionnaires. 3 types of messages: 1) Reminders for completing web-based questionnaires, the attendance at group sessions and the follow-up appointments, 2) General advice on good habits, 3) Custom messages to reinforce behavior change.
Multifaceted intervention consisting of: * Educational intervention: Two theoretical and practical sessions to update knowledge on T2DM management and provide professionals with techniques to enhance the patient-centered clinical relationship model and the shared decision making model with the ultimate goal of improving patient adherence to treatment and self-care. * Computer-based clinical decision support system (CDSS): Implementation of an automated tool combining evidence-based knowledge with patient-specific information to assist clinicians in making clinical decisions in the management of T2DM patients. * Feedback: periodic mailing of personalized feedback reports with data on health results of all T2DM patients who are cared by the professional.
Usual care for T2DM received in primary health care
Eligibility Criteria
You may qualify if:
- Patients:
- T2DM diagnosis
- aged between 18 and 65
- Health professionals:
- primary health care teams (PHCT) comprising a primary care physician and a nurse practitioner associated to a patient will be selected
- must have a permanent position or a stable substitute position
You may not qualify if:
- peripheral vascular disease
- diabetic nephropathy and/or chronic kidney disease
- cognitive impairment, dementia
- major depression
- insufficient level of Spanish
- to be pregnant or planning to become pregnant in the next 6 months
- cancer last 5 years
- ischemic disease or heart failure
- proliferative diabetic retinopathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Servicio Canario de Saludlead
- Instituto de Salud Carlos IIIcollaborator
- Asociación para la Diabetes de Tenerifecollaborator
- Asociación de Diabéticos de Gran Canariacollaborator
Study Sites (1)
Servicio de Evaluación del Servicio Canario de la Salud
Santa Cruz de Tenerife, 38004, Spain
Related Publications (4)
Garcia-Perez L, Ramallo-Farina Y, Vallejo-Torres L, Rodriguez-Rodriguez L, Gonzalez-Pacheco H, Santos-Hernandez B, Garcia-Bello MA, Wagner AM, Carmona M, Serrano-Aguilar PG; INDICA team. Cost-effectiveness of multicomponent interventions in type 2 diabetes mellitus in a cluster randomised controlled trial: the INDICA study. BMJ Open. 2022 Apr 8;12(4):e058049. doi: 10.1136/bmjopen-2021-058049.
PMID: 35396305DERIVEDRamallo-Farina Y, Rivero-Santana A, Garcia-Perez L, Garcia-Bello MA, Wagner AM, Gonzalez-Pacheco H, Rodriguez-Rodriguez L, Kaiser-Girardot S, Monzon-Monzon G, Guerra-Marrero C, Daranas-Aguilar C, Roldan-Ruano M, Carmona M, Serrano-Aguilar PG; INDICA Team. Patient-reported outcome measures for knowledge transfer and behaviour modification interventions in type 2 diabetes-the INDICA study: a multiarm cluster randomised controlled trial. BMJ Open. 2021 Dec 15;11(12):e050804. doi: 10.1136/bmjopen-2021-050804.
PMID: 34911711DERIVEDRamallo-Farina Y, Garcia-Bello MA, Garcia-Perez L, Boronat M, Wagner AM, Rodriguez-Rodriguez L, de Pablos-Velasco P, Llorente Gomez de Segura I, Gonzalez-Pacheco H, Carmona Rodriguez M, Serrano-Aguilar P; INDICA Team. Effectiveness of Internet-Based Multicomponent Interventions for Patients and Health Care Professionals to Improve Clinical Outcomes in Type 2 Diabetes Evaluated Through the INDICA Study: Multiarm Cluster Randomized Controlled Trial. JMIR Mhealth Uhealth. 2020 Nov 2;8(11):e18922. doi: 10.2196/18922.
PMID: 33136059DERIVEDRamallo-Farina Y, Garcia-Perez L, Castilla-Rodriguez I, Perestelo-Perez L, Wagner AM, de Pablos-Velasco P, Dominguez AC, Cortes MB, Vallejo-Torres L, Ramirez ME, Martin PP, Garcia-Puente I, Salinero-Fort MA, Serrano-Aguilar PG; INDICA team. Effectiveness and cost-effectiveness of knowledge transfer and behavior modification interventions in type 2 diabetes mellitus patients--the INDICA study: a cluster randomized controlled trial. Implement Sci. 2015 Apr 9;10:47. doi: 10.1186/s13012-015-0233-1.
PMID: 25880498DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pedro G Serrano-Aguilar, MD, PhD
Servicio de Evaluación del Servicio Canario de la Salud
- STUDY DIRECTOR
Pedro Serrano Aguilar, MD, PhD
Servicio de Evaluación del Servicio Canario de la Salud
- STUDY CHAIR
Pedro Serrano Aguilar, MD, PhD
Servicio de Evaluación del Servicio Canario de la Salud
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Participating FCUs were not told about their intervention assignment (groups 1-4) until the last patient agreed to participate at every FCU. To warrant patient participation and cooperation, interventions could neither be blinded to patients nor to healthcare professionals. Data analysis is blinded to the intervention assignment.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 31, 2012
First Posted
August 6, 2012
Study Start
January 1, 2013
Primary Completion
October 20, 2016
Study Completion
October 20, 2016
Last Updated
October 4, 2021
Record last verified: 2021-09